BeiGene, Ltd. (NASDAQ: ONC) reported Q3 EPS of $2.65, $1.85 better than the analyst estimate of $0.80. Revenue for the quarter came in at $1.41 billion versus the consensus estimate of $1.37 billion.

GUIDANCE:

BeiGene, Ltd. sees FY2025 revenue of $5.1-5.3 billion, versus the consensus of $3.754 billion.

For earnings history and earnings-related data on BeiGene, Ltd. (ONC) click here.